These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 1741567)

  • 1. [Molecular analysis of the androgen receptor gene in androgen resistance syndrome].
    Sultan C; Lobacarro JM; Ruiz-Pacheco R; Moustarih R; Medlej R
    An Esp Pediatr; 1991 May; 34 Suppl 44():3-8. PubMed ID: 1741567
    [No Abstract]   [Full Text] [Related]  

  • 2. Androgen receptor point mutations as the underlying molecular defect in 2 patients with androgen insensitivity syndrome.
    Radmayr C; Culig Z; Glatzl J; Neuschmid-Kaspar F; Bartsch G; Klocker H
    J Urol; 1997 Oct; 158(4):1553-6. PubMed ID: 9302173
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Peripheral androgen resistance syndrome].
    Bernasconi S; Ghizzoni L; Panza C; Giovannelli G
    Pediatr Med Chir; 1989; 11(5):485-90. PubMed ID: 2698465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Familial form of partial androgen insensitivity (Reifenstein syndrome): arginine-histidine mutation in position 840 in the androgen receptor].
    Lumbroso S; Lobaccaro JM; Belon C; Amram S; Rodier M; Bringer J; Sultan C
    C R Seances Soc Biol Fil; 1993; 187(4):508-15. PubMed ID: 8019921
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A case of male pseudohermaphroditism with normal androgen receptor binding and 47,XYY karyotype.
    Bosch-Banyeras JM; Audi L; Sarret E; Bau A; Bosch-Marcet J; Bernet M; Iriondo L; Cuatrecasas JM
    Ann Genet; 1985; 28(2):125-9. PubMed ID: 3876063
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen receptors and partial androgen insensitivity in male pseudohermaphroditism.
    Sultan C
    Ann Genet; 1986; 29(1):5-10. PubMed ID: 3521447
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Androgen insensitivity syndromes].
    Kuttenn F; Wright F; Spritzer P; Mowszowicz I; Mauvais-Jarvis P
    Ann Urol (Paris); 1987; 21(4):227-34. PubMed ID: 3314678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia and the androgen receptor gene: report of a sibship showing co-segregation with Reifenstein syndrome but no evidence for linkage in 23 multiply affected families.
    Arranz M; Sharma T; Sham P; Kerwin R; Nanko S; Owen M; Gill M; Collier D
    Am J Med Genet; 1995 Oct; 60(5):377-81. PubMed ID: 8546149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Male pseudohermaphroditism caused by partial insensitivity to androgens. Clinical and biochemical heterogeneity].
    Sultan C; Terraza A; Chabab A; Arlot S; Loire C; Fenart O; Garandeau P; Jean R
    Arch Fr Pediatr; 1985; 42 Suppl 1():569-74. PubMed ID: 4083989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgens, androgen receptors, and male gender role behavior.
    Wilson JD
    Horm Behav; 2001 Sep; 40(2):358-66. PubMed ID: 11534997
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and molecular spectrum of androgen insensitivity syndromes.
    Hiort O; Sinnecker GH; Holterhus PM; Nitsche EM; Kruse K
    Am J Med Genet; 1996 May; 63(1):218-22. PubMed ID: 8723113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Substitution of arginine-839 by cysteine or histidine in the androgen receptor causes different receptor phenotypes in cultured cells and coordinate degrees of clinical androgen resistance.
    Beitel LK; Kazemi-Esfarjani P; Kaufman M; Lumbroso R; DiGeorge AM; Killinger DW; Trifiro MA; Pinsky L
    J Clin Invest; 1994 Aug; 94(2):546-54. PubMed ID: 8040309
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ala 586 Asp mutation in androgen receptor disrupts transactivation function without affecting androgen binding.
    Rajender S; Gupta NJ; Chakrabarty B; Singh L; Thangaraj K
    Fertil Steril; 2009 Mar; 91(3):933.e23-8. PubMed ID: 19062009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the molecular consequences of different mutations at residue 754 and 690 of the androgen receptor (AR) and androgen insensitivity syndrome (AIS) phenotype.
    Tadokoro R; Bunch T; Schwabe JW; Hughes IA; Murphy JC
    Clin Endocrinol (Oxf); 2009 Aug; 71(2):253-60. PubMed ID: 19178528
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular analysis of familial androgen insensitivity syndrome due to replacement of glutamic acid 802 by lysine.
    Sawai H; Komori S; Sakata K; Nakae K; Shima H; Matsumoto F; Matsumoto H; Onishi Y; Okada Y; Yoshida O; Koyama K
    J Hum Genet; 2000; 45(6):342-5. PubMed ID: 11185742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term followup and comparison between genotype and phenotype in 29 cases of complete androgen insensitivity syndrome.
    Cheikhelard A; Morel Y; Thibaud E; Lortat-Jacob S; Jaubert F; Polak M; Nihoul-Fekete C
    J Urol; 2008 Oct; 180(4):1496-501. PubMed ID: 18710728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete androgen insensitivity syndrome: clinical and anatomopathological findings in 23 patients.
    Alvarez-Nava F; Gonzalez S; Soto M; Martinez C; Prieto M
    Genet Couns; 1997; 8(1):7-12. PubMed ID: 9101272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Genetics and endocrinology of male sex differentiation: application to molecular study of male pseudohermaphroditism].
    Sultan C; Lumbroso S; Poujol N; Boudon C; Georget V; Térouanne B; Belon C; Lobaccaro JM
    C R Seances Soc Biol Fil; 1995; 189(5):713-40. PubMed ID: 8673622
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical consequences of androgen receptor malfunction].
    Klocker H; Eder IE; Culig Z; Bartsch G
    Verh Dtsch Ges Pathol; 2004; 88():122-9. PubMed ID: 16892542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular analysis of androgen resistance syndromes in Egyptian patients.
    Essawi M; Gad YZ; el-Rouby O; Temtamy SA; Sabour YA; el-Awady MK
    Dis Markers; 1997 Apr; 13(2):99-105. PubMed ID: 9160185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.